Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations

PURPOSE: BRAF mutations occur in non–small-cell lung cancer. Therapies targeting BRAF mutant tumors have recently been identified. We undertook this study to determine the clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. PATIENTS AND METHODS: We reviewed data...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Paik, Paul K., Arcila, Maria E., Fara, Michael, Sima, Camelia S., Miller, Vincent A., Kris, Mark G., Ladanyi, Marc, Riely, Gregory J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2011
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107760/
https://ncbi.nlm.nih.gov/pubmed/21483012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.1280
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky